129 related articles for article (PubMed ID: 21083054)
1. Bioanalytical issues in patient-friendly sampling methods for therapeutic drug monitoring: focus on antiretroviral drugs.
ter Heine R; Beijnen JH; Huitema AD
Bioanalysis; 2009 Oct; 1(7):1329-38. PubMed ID: 21083054
[TBL] [Abstract][Full Text] [Related]
2. Nevirapine concentration in nonstimulated saliva: an alternative to plasma sampling in children with human immunodeficiency virus infection.
Rakhmanina NY; Capparelli EV; van den Anker JN; Williams K; Sever JL; Spiegel HM; Soldin SJ
Ther Drug Monit; 2007 Feb; 29(1):110-7. PubMed ID: 17304158
[TBL] [Abstract][Full Text] [Related]
3. Applicability of bioanalysis of multiple analytes in drug discovery and development: review of select case studies including assay development considerations.
Srinivas NR
Biomed Chromatogr; 2006 May; 20(5):383-414. PubMed ID: 16307470
[TBL] [Abstract][Full Text] [Related]
4. Hair as a biological specimen for therapeutic drug monitoring.
Beumer JH; Bosman IJ; Maes RA
Int J Clin Pract; 2001; 55(6):353-7. PubMed ID: 11501221
[TBL] [Abstract][Full Text] [Related]
5. Determination of tobramycin in saliva is not suitable for therapeutic drug monitoring of patients with cystic fibrosis.
Madsen V; Lind A; Rasmussen M; Coulthard K
J Cyst Fibros; 2004 Dec; 3(4):249-51. PubMed ID: 15698943
[TBL] [Abstract][Full Text] [Related]
6. Measurement of xenobiotics in saliva: is saliva an attractive alternative matrix? Case studies and analytical perspectives.
Mullangi R; Agrawal S; Srinivas NR
Biomed Chromatogr; 2009 Jan; 23(1):3-25. PubMed ID: 18816455
[TBL] [Abstract][Full Text] [Related]
7. Principles of therapeutic drug monitoring.
Zhao W; Jacqz-Aigrain E
Handb Exp Pharmacol; 2011; 205():77-90. PubMed ID: 21882106
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic drug monitoring of nevirapine in resource-limited settings.
L'homme RF; Muro EP; Droste JA; Wolters LR; van Ewijk-Beneken Kolmer NW; Schimana W; Burger DM
Clin Infect Dis; 2008 Nov; 47(10):1339-44. PubMed ID: 18922070
[TBL] [Abstract][Full Text] [Related]
9. Clinical Value of Emerging Bioanalytical Methods for Drug Measurements: A Scoping Review of Their Applicability for Medication Adherence and Therapeutic Drug Monitoring.
Zijp TR; Izzah Z; Åberg C; Gan CT; Bakker SJL; Touw DJ; van Boven JFM
Drugs; 2021 Nov; 81(17):1983-2002. PubMed ID: 34724175
[TBL] [Abstract][Full Text] [Related]
10. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
11. Capillary electrophoresis for therapeutic drug monitoring.
Brunner LJ; DiPiro JT
Electrophoresis; 1998 Nov; 19(16-17):2848-55. PubMed ID: 9870379
[TBL] [Abstract][Full Text] [Related]
12. An overview of the use of urine, hair, sweat and saliva to detect drug use.
Dolan K; Rouen D; Kimber J
Drug Alcohol Rev; 2004 Jun; 23(2):213-7. PubMed ID: 15370028
[TBL] [Abstract][Full Text] [Related]
13. Dried blood spots in toxicology: from the cradle to the grave?
Stove CP; Ingels AS; De Kesel PM; Lambert WE
Crit Rev Toxicol; 2012 Mar; 42(3):230-43. PubMed ID: 22348353
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic drug monitoring and the inhibitory quotient of antiretroviral drugs: can they be applied to the current situation?
Ribera E; López-Cortés LF; Soriano V; Casado JL; Mallolas J
Enferm Infecc Microbiol Clin; 2005 Jul; 23 Suppl 2():41-67. PubMed ID: 16373004
[TBL] [Abstract][Full Text] [Related]
15. Determination of saliva trough levels for monitoring voriconazole therapy in immunocompromised children and adults.
Michael C; Bierbach U; Frenzel K; Lange T; Basara N; Niederwieser D; Mauz-Körholz C; Preiss R
Ther Drug Monit; 2010 Apr; 32(2):194-9. PubMed ID: 20216120
[TBL] [Abstract][Full Text] [Related]
16. The use of oral fluid for therapeutic drug management: clinical and forensic toxicology.
Langman LJ
Ann N Y Acad Sci; 2007 Mar; 1098():145-66. PubMed ID: 17332075
[TBL] [Abstract][Full Text] [Related]
17. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
18. [The value of plasma antiretroviral drug monitoring in the management of HIV infected patients].
Tréluyer JM
Ann Med Interne (Paris); 2000 Jun; 151(4):291-6. PubMed ID: 10922957
[TBL] [Abstract][Full Text] [Related]
19. Dried blood spot methods in therapeutic drug monitoring: methods, assays, and pitfalls.
Edelbroek PM; van der Heijden J; Stolk LM
Ther Drug Monit; 2009 Jun; 31(3):327-36. PubMed ID: 19349929
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic drug monitoring of antiretroviral agents scenario.
Moltó J; Clotet B
J HIV Ther; 2004 Nov; 9(4):75-8. PubMed ID: 15731738
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
